ATE60234T1 - Diaetetische und pharmazeutische zusammensetzungen, enthaltend methylsulfonylmethan. - Google Patents

Diaetetische und pharmazeutische zusammensetzungen, enthaltend methylsulfonylmethan.

Info

Publication number
ATE60234T1
ATE60234T1 AT83109006T AT83109006T ATE60234T1 AT E60234 T1 ATE60234 T1 AT E60234T1 AT 83109006 T AT83109006 T AT 83109006T AT 83109006 T AT83109006 T AT 83109006T AT E60234 T1 ATE60234 T1 AT E60234T1
Authority
AT
Austria
Prior art keywords
compositions containing
methylsulfonylmethane
dietical
pharmaceutical compositions
containing methylsulfonylmethane
Prior art date
Application number
AT83109006T
Other languages
English (en)
Inventor
Robert J Herschler
Original Assignee
Herschler R J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herschler R J filed Critical Herschler R J
Application granted granted Critical
Publication of ATE60234T1 publication Critical patent/ATE60234T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT83109006T 1982-09-14 1983-09-13 Diaetetische und pharmazeutische zusammensetzungen, enthaltend methylsulfonylmethan. ATE60234T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/418,110 US4514421A (en) 1979-08-30 1982-09-14 Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
EP83109006A EP0103836B1 (de) 1982-09-14 1983-09-13 Diätetische und pharmazeutische Zusammensetzungen, enthaltend Methylsulfonylmethan

Publications (1)

Publication Number Publication Date
ATE60234T1 true ATE60234T1 (de) 1991-02-15

Family

ID=23656756

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83109006T ATE60234T1 (de) 1982-09-14 1983-09-13 Diaetetische und pharmazeutische zusammensetzungen, enthaltend methylsulfonylmethan.

Country Status (13)

Country Link
US (1) US4514421A (de)
EP (1) EP0103836B1 (de)
JP (1) JPS59501748A (de)
AT (1) ATE60234T1 (de)
AU (2) AU564536B2 (de)
CA (1) CA1219218A (de)
DE (1) DE3382136D1 (de)
DK (1) DK238384A (de)
NO (1) NO841909L (de)
NZ (1) NZ205571A (de)
PH (1) PH20568A (de)
SU (1) SU1443788A3 (de)
WO (1) WO1984001105A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863748A (en) * 1979-08-30 1989-09-05 Herschler R J Dietary products and uses comprising methylsulfonylmethane
US4616039A (en) * 1979-08-30 1986-10-07 Herschler R J Methylsulfonylmethane in dietary products
US4914135A (en) * 1979-08-30 1990-04-03 Herschler R J Use of Methylsulfonylmethane to treat parasitic infections
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
WO1994005293A1 (en) * 1992-09-04 1994-03-17 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
GB9218711D0 (en) * 1992-09-04 1992-10-21 Salim Aws S M Skin cancer treatment
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
JPH11504939A (ja) * 1995-05-09 1999-05-11 ザ、プロクター、エンド、ギャンブル、カンパニー 胃腸障害の治療及び予防用のビスマス含有組成物
AU5439696A (en) * 1995-08-24 1997-03-19 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
NO314979B1 (no) * 1995-12-07 2003-06-23 Procter & Gamble Anvendelse av vismut for fremstilling av et preparat for behandling eller forebygging av en urogenital lidelse
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
EP0865285B1 (de) * 1995-12-07 2002-01-16 The Procter & Gamble Company Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
US7718694B2 (en) * 1997-10-16 2010-05-18 Children's Hospital & Research Center At Oakland Compositions and methods for therapy for diseases characterized by defective chloride transport
US6203820B1 (en) 1998-05-28 2001-03-20 Brice E. Vickery Compositions and methods for enhancing protein anabolism and detoxification
PT1220678E (pt) * 1999-10-04 2007-06-11 John Carter Composições farmacêuticas contendo cobre, ácido salicílico e vitamina c
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6759062B2 (en) 2000-02-23 2004-07-06 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6841544B2 (en) * 2000-02-23 2005-01-11 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6793942B2 (en) 2000-02-23 2004-09-21 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6403116B1 (en) 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US20040038864A1 (en) * 2002-06-27 2004-02-26 Per Balschmidt Use of dimethyl sulfone as isotonicity agent
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US20040082667A1 (en) * 2002-10-16 2004-04-29 Mccadden Kenneth Hangover treatment
JP2005298412A (ja) * 2004-04-13 2005-10-27 Minato Pharmaceutical Co Ltd 被覆粒子
JPWO2005112667A1 (ja) * 2004-05-20 2008-03-27 隆史 大森 健康食品
ITBS20040068A1 (it) * 2004-05-24 2004-08-24 Gen Topics Srl Composizione cosmetica e/o farmaceutica per il trattamento della rosacea
US20060147423A1 (en) * 2004-12-07 2006-07-06 Jean-Yves Legendre Transungual device
EP2324838A1 (de) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Zusammensetzungen mit Dimethyl-Sulfoxid
CA2622204C (en) 2005-09-12 2016-10-11 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US7754256B2 (en) * 2007-03-07 2010-07-13 Stan Dennison Nutritional composition
BRPI0921494A2 (pt) * 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
EP2424348A1 (de) * 2009-04-30 2012-03-07 Bakteriefritt AS Zusammensetzung zum sterilisieren von oberflächen
CN102724973B (zh) 2009-10-30 2014-08-27 生物基因创新有限责任公司 用于处理药物抗性微生物的甲基磺酰甲烷（msm）
EP2493314B1 (de) 2009-10-30 2020-04-08 Abela Pharmaceuticals, Inc. Dimethylsulfoxid (dmso)- und methylsulfonylmethan (msm)-formulierungen zur behandlung von osteoarthritis
EP2552200B1 (de) * 2010-03-31 2015-10-14 Abela Pharmaceuticals, Inc. Dimethylsulfoxid (dmso-)formulierungen zur behandlung von autismus
MX355103B (es) 2012-04-02 2018-04-05 Eaglepharma Pty Ltd Composicion para el tratamiento de desordenes inflamatorios e inmunes.
US20160303035A1 (en) * 2014-07-16 2016-10-20 Bio Nano Trinity. Co. Ltd Toothpaste Composition Containing Curcuma Longa L. and Method of Manufacturing Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL26209A (en) * 1965-08-02 1970-10-30 Merck & Co Inc Pharmaceutical compositions containing substituted sulphones
US4333922A (en) * 1974-09-12 1982-06-08 Herschler R J Method for the treatment of water-living animals with health modifying agents
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US4296130A (en) * 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use

Also Published As

Publication number Publication date
DK238384D0 (da) 1984-05-14
AU599670B2 (en) 1990-07-26
JPS59501748A (ja) 1984-10-18
AU7473287A (en) 1987-10-08
NO841909L (no) 1984-05-11
DK238384A (da) 1984-05-14
WO1984001105A1 (en) 1984-03-29
EP0103836A2 (de) 1984-03-28
AU564536B2 (en) 1987-08-13
SU1443788A3 (ru) 1988-12-07
PH20568A (en) 1987-02-18
EP0103836A3 (en) 1986-07-30
US4514421A (en) 1985-04-30
DE3382136D1 (de) 1991-02-28
CA1219218A (en) 1987-03-17
AU2039683A (en) 1984-04-04
NZ205571A (en) 1986-09-10
EP0103836B1 (de) 1991-01-23

Similar Documents

Publication Publication Date Title
ATE60234T1 (de) Diaetetische und pharmazeutische zusammensetzungen, enthaltend methylsulfonylmethan.
DE69313983D1 (de) Ein Guanidinothiazol und Antazida enthaltende Arzneimittel
ATE66368T1 (de) Sich schnell verfluessigende kautablette.
FR2604090B1 (fr) Forme de dosage pharmaceutique solide comprenant au moins une unite a liberation controlee
IE862554L (en) Pharmaceutical compositions
DE69940674D1 (de) Orale verabreichung von adenosin analogen
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
DK0396165T3 (da) Farmaceutisk præparat til oral indgift til gastrointestinal udskylning eller som katarlaxativ
KR910009273A (ko) 위장관계 통증 치료용 약제학적 조성물
JPS6466159A (en) Vanadyl organic-inorganic compound and manufacture of drug composition containing same
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
KR850700212A (ko) 서방성 약제학적 캼셀제
US4743596A (en) Anti-arthritic preparation
ATE101039T1 (de) Oral anzuwendende arzneimittel in einzeldosisform.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
BR9712964A (pt) Embalagem para concordância e método para melhorar ou ajudar a concordância do paciente para dietas com remédio complexo.
KR890009400A (ko) 다이클로닌 Hcl및 페놀을 함유하는 약제학적 조성물
ATE15331T1 (de) Verfahren fuer die orale verabreichung von substanzen in der form von liposomen, und ihre pharmazeutischen zusammensetzungen.
Lieber et al. Complications resulting from renal failure in patients with liver disease
ATE44461T1 (de) Analgetische zusammensetzungen.
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
US4446132A (en) Nontoxic aspirin composition
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
Abramowitz Historical points of interest on the mode of action and ill effects of mercury
PT84580A (en) Process for the preparation of pharmaceutical compositions containing indomethacin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee